首页 | 本学科首页   官方微博 | 高级检索  
     

重组人结缔组织生长因子对人成骨细胞膜型基质金属蛋白酶1及基质金属蛋白酶2表达的影响
引用本文:隋国良,彭依群,何玉玲,翟木绪,廖二元. 重组人结缔组织生长因子对人成骨细胞膜型基质金属蛋白酶1及基质金属蛋白酶2表达的影响[J]. 中华内分泌代谢杂志, 2011, 27(3). DOI: 10.3760/cma.j.issn.1000-6699.2011.03.016
作者姓名:隋国良  彭依群  何玉玲  翟木绪  廖二元
作者单位:1. 山东省烟台市烟台山医院内分泌科
2. 中南大学湘雅二医院代谢内分泌研究所,长沙,410011
摘    要:
使用重组人结缔组织生长因子(recombinant human connective tissue growth factor,rCTGF)干预体外培养的人成骨细胞,发现rCTGF可呈时间-剂量依赖性地促进人成骨细胞膜型基质金属蛋白酶1及基质金属蛋白酶2的表达,200 ng/ml CTGF作用24~48 h达最大效果.rCTGF可明显增强p38丝裂原活化的蛋白激酶(p38-MAPK)磷酸化,p38-MAPK阻断剂SB 23058可阻断rCTGF上调膜型基质金属蛋白酶1及基质金属蛋白酶2的效应.
Abstract:
Human osteoblast was treated with recombinant human connective tissue growth factor (rCTGF). This experiment showed that rCTGF increased membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 protein expression in a dose- and time-depentent manner in human osteoblasts. rCTGF induced activation of p38 MAPK in human osteoblasts. p38 MAPK inhibitor SB23058 abrogated the effect of rCTGF on the expressions of membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 in human osteoblasts.

关 键 词:重组人结缔组织生长因子  成骨细胞  膜型基质金属蛋白酶-1  基质金属蛋白酶-2

Effect of recombinant human connective tissue growth factor on the expression of membrane type-1 matrix metalloproteinase and matrix metalloproteinase 2 in human osteoblasts
SUI Guo-liang,PENG Yi-qun,HE Yu-ling,ZHAI Mu-xu,LIAO Er-yuan. Effect of recombinant human connective tissue growth factor on the expression of membrane type-1 matrix metalloproteinase and matrix metalloproteinase 2 in human osteoblasts[J]. Chinese Journal of Endocrinology and Metabolism, 2011, 27(3). DOI: 10.3760/cma.j.issn.1000-6699.2011.03.016
Authors:SUI Guo-liang  PENG Yi-qun  HE Yu-ling  ZHAI Mu-xu  LIAO Er-yuan
Abstract:
Human osteoblast was treated with recombinant human connective tissue growth factor (rCTGF). This experiment showed that rCTGF increased membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 protein expression in a dose- and time-depentent manner in human osteoblasts. rCTGF induced activation of p38 MAPK in human osteoblasts. p38 MAPK inhibitor SB23058 abrogated the effect of rCTGF on the expressions of membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 in human osteoblasts.
Keywords:Recombinant human connective tissue growth factor  Human osteoblast  Membrane type-1 matrix metalloproteinase  Matrix metalloproteinase-2
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号